CVS Health (NYSE:CVS) Raised to "Strong-Buy" at Wall Street Zen

Key Points

• Wall Street Zen upgraded CVS Health to “strong-buy” from “buy.” Overall analyst sentiment remains positive, with 22 buy ratings and one hold, producing a “moderate buy” consensus and an average price target of $107.24.
• CVS reported stronger-than-expected quarterly results, posting $2.58 in adjusted EPS versus the $1.87 consensus and $106.1 billion in revenue. Revenue increased 7.3% year over year, while fiscal 2026 EPS guidance was set at $7.90–$8.10.
• Institutional investors hold approximately 80.66% of CVS shares, with notable second-quarter buying by BlackRock, Wellington Management and Bank of America. Shares opened at $89.02, below the analyst consensus target.

CVS Health (NYSE:CVS - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating in a report released on Sunday, Wall Street Zen reports.

Several other equities research analysts have also weighed in on CVS. HSBC reissued a "hold" rating and set a $103.00 price objective on shares of CVS Health in a research note on Monday, July 6th. Wells Fargo & Company boosted their target price on CVS Health from $103.00 to $123.00 and gave the stock an "overweight" rating in a research report on Monday, July 13th. Sanford C. Bernstein reiterated an "outperform" rating and issued a $112.00 price target on shares of CVS Health in a research report on Wednesday, September 9th. Barclays lifted their price target on CVS Health from $106.00 to $108.00 and gave the stock an "overweight" rating in a research note on Thursday, August 6th. Finally, Cantor Fitzgerald restated an "overweight" rating on shares of CVS Health in a report on Friday, September 11th. Twenty-two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $107.24.

CVS Health Stock Performance

Shares of CVS opened at $89.02 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. The firm's 50 day moving average is $98.79 and its 200-day moving average is $91.30. CVS Health has a 12-month low of $69.51 and a 12-month high of $110.68. The stock has a market capitalization of $113.86 billion, a P/E ratio of 23.55, a P/E/G ratio of 0.87 and a beta of 0.59.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating the consensus estimate of $1.87 by $0.71. The business had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business's quarterly revenue was up 7.3% on a year-over-year basis. During the same period in the prior year, the business earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities research analysts anticipate that CVS Health will post 8.02 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in CVS. BlackRock Inc. acquired a new stake in CVS Health in the 2nd quarter worth approximately $12,747,462,000. State Street Corp raised its position in shares of CVS Health by 2.1% in the fourth quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator's stock valued at $4,776,182,000 after purchasing an additional 1,245,457 shares during the period. Wellington Management Group LLP raised its position in shares of CVS Health by 49.8% in the second quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator's stock valued at $3,496,725,000 after purchasing an additional 11,233,381 shares during the period. Bank of America Corp DE lifted its stake in shares of CVS Health by 148.0% in the second quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator's stock worth $2,398,868,000 after buying an additional 13,836,701 shares during the last quarter. Finally, Capital International Investors boosted its holdings in shares of CVS Health by 3.4% during the 4th quarter. Capital International Investors now owns 27,592,356 shares of the pharmacy operator's stock worth $2,189,793,000 after buying an additional 900,153 shares during the period. Institutional investors and hedge funds own 80.66% of the company's stock.

Trending Headlines about CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Aetna is streamlining oncology prior authorizations. CVS’s insurance unit plans to reduce cancer-treatment approvals to one initial medical prior authorization, with bundled approvals expanding across eligible Medicaid members and all Aetna business lines in 2027. The move could lower administrative costs, reduce provider friction and accelerate member access to care. Reuters article
• Positive Sentiment: Margin improvement remains a potential catalyst. A Trefis analysis highlighted management’s efforts to rebuild Aetna’s profitability. With CVS generating only about a 1.2% net margin on $415.1 billion of revenue, even modest margin expansion could materially increase earnings and support the investment case. Trefis article
• Neutral Sentiment: Operational and community initiatives offer limited immediate financial impact. CVS discussed using digital-twin technology to improve decision-making and speed, while also redeveloping a youth soccer pitch with Seattle Reign FC and the RAVE Foundation. These initiatives may support efficiency and brand reputation but are unlikely to materially affect near-term earnings. Digital twins article Soccer pitch article
• Negative Sentiment: Omnicare has completed its Chapter 11 liquidation. The closure removes an underperforming operation, but the bankruptcy highlights restructuring and execution challenges within CVS’s broader business. TheStreet article

About CVS Health

CVS Health Corporation is an American health care company headquartered in Woonsocket, Rhode Island. Founded in 1963 as Consumer Value Stores, the company has expanded from a chain of retail pharmacies into an integrated health care organization serving consumers, employers, health plans, government programs and health care providers.

CVS Health operates through several major businesses. Its Health Care Benefits segment, anchored by Aetna, provides health insurance products and related services for employers, individuals, Medicare and Medicaid members.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.